Description
Phorbol 12,3-dibutyrate (PDBu) activates PKC and PKD and induces apoptosis and differentiation in leukemia cells. PBDu is carcinogenic.
Product Unit Size | Cost | Quantity | Stock |
---|
Phorbol 12,3-dibutyrate (PDBu) activates PKC and PKD and induces apoptosis and differentiation in leukemia cells. PBDu is carcinogenic.
Cas No. | 37558-16-0 |
---|---|
Purity | ≥98% |
Formula | C28H40O8 |
Formula Wt. | 504.61 |
IUPAC Name | [(1S,2S,6R,10S,11R,13S,14R,15R)-13-butanoyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] butanoate |
Synonym | PDBu |
Solubility | Soluble in DMSO or ethanol. |
Appearance | Amorphous solid |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Aicart-Ramos C, Sánchez-Ruiloba L, Gómez-Parrizas M, et al. Protein kinase D activity controls endothelial nitric oxide synthesis. J Cell Sci. 2014 Aug 1;127(Pt 15):3360-72. PMID: 24928905.
Terui Y, Furukawa Y, Kikuchi J, et al. Apoptosis during HL-60 cell differentiation is closely related to a G0/G1 cell cycle arrest. J Cell Physiol. 1995 Jul;164(1):74-84. PMID: 7790399.
Rais S, Combadiere C, Hakim J, et al. Staurosporine up-regulates the expression of phorbol dibutyrate binding sites in human platelets. Biochem Pharmacol. 1994 May 18;47(10):1797-804. PMID: 8204096.
β2-adrenergic agonist.
Pyrimidine nucleoside base, pairs with adenosin...
Semi-synthetic avermectin; GABA potentiator.
Aminothiol, CoA component; ulcer inducer.
HSP90 inhibitor.
Tetrapeptide, binds cell surface integrins.
Optically active isomer of ibuprofen, NSAID; CO...
Histamine H1 antagonist, FIASMA.
Hec1/Nek2 mitotic pathway inhibitor
Bumetanide impurity
NO donor; AR antagonist.
Basic phenol skeleton structure found in variou...
Cannabinoid receptor 2 selective agonist.
Pyrimidine nucleoside (cytidine) analog; DNA ch...
ACE inhibitor.
Coumarin; VKORC1 inhibitor.
Vitamin A carboxylic acid; RAR agonist.
α4β2 nAChR desensitizer, delayed-rectifier vo...
Phytohormone
D2 and 5-HT1A partial agonist, 5-HT2C/6/7 antag...